Principles of medicating children with neurodevelopmental and sleep disorders--a review

Kenneth Nunn1

  • 1Child Psychiatrist and Neuropsychiatrist, Department of Psychological Medicine, The Children's Hospital at Westmead, Locked Bag 4001, Westmead, Sydney, NSW, Australia 2145.

Insights

Environmental conflicts with a child's intrinsic sleep signature cause stress and behavioral issues. Addressing these conflicts requires considering both medication and social support systems for effective sleep regulation.

Area of Science:

  • Child psychology
  • Neurodevelopmental disorders
  • Sleep medicine

Background:

  • Childhood stress and behavioral difficulties often stem from a mismatch between environmental demands and intrinsic sleep patterns.
  • Distorted development, particularly in the brain, can lead to altered intrinsic sleep signatures.
  • The interplay between a child's sleep signature and their environment significantly impacts sleep-behavioral outcomes.

Purpose of the Study:

  • To explore the impact of environmental factors on children's sleep signatures and stress-related behaviors.
  • To discuss the modification of sleep-behavioral outcomes through medical and non-medical interventions.
  • To outline strategies for managing treatment-resistant cases, emphasizing sleep regulation and non-medication factors.

Main Methods:

  • Review of existing literature on child development, sleep, and environmental influences.
  • Analysis of clinical observations regarding the efficacy of different intervention strategies.
  • Discussion of factors contributing to treatment failure in vulnerable populations.

Main Results:

  • Conflict between environmental demands and intrinsic sleep signatures creates stress-behavior difficulties.
  • Medications can alter sleep signatures and stress responses, while non-medical interventions address environmental factors.
  • For non-responders to stimulatory medication, inhibitory strategies and prioritizing sleep regulation are crucial.

Conclusions:

  • Effective management of sleep-behavioral difficulties requires a dual approach, integrating medication with serious consideration of social networks.
  • Re-evaluating medication priorities, shifting towards inhibitory strategies and sleep regulation, is vital for treatment-resistant children.
  • Clinicians must be alert to non-medication factors that may impede treatment success in vulnerable children.

Related Concept Videos

Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...